Samsung Bioepis Co., Ltd. v. Janssen Biotech, Inc. > Summary
Court Case Number IPR2023-01103
Filing Date Jun 21, 2023
Institution Decision Date -
Decision Date Aug 9, 2023
Court Patent Trial and Appeal Board
Status Terminated-Settled
Claims Challenged in the Petition: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34
Petitioner
Patent Owner
Petitioner Attorneys
3samsung bioepis
Attorney Name: Noah S. Frank
Kirkland & Ellis
samsung bioepis
Attorney Name: Todd Baker
Kirkland & Ellis
samsung bioepis
Attorney Name: Jeanna M. Wacker
Kirkland & Ellis
Patent Owner Attorneys
4Janssen Biotech, Inc.
Attorney Name: Michael A. Morin
Latham & Watkins
Janssen Biotech, Inc.
Attorney Name: Inge A. Osman
Latham & Watkins
Janssen Biotech, Inc.
Attorney Name: Roger J. Chin
Latham & Watkins
Janssen Biotech, Inc.
Attorney Name: David A. Lane Jr.
Johnson & Johnson
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10961307 | Methods of treating moderately to severely active ulcerative colitis by administering an anti-IL12/IL23 antibody | Mar 30, 2021 |
